SS

Sarita Sinha

Active Director Director DIN 08762878
DIN 08762878 First appointment Jun 2020 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value •••• Premium profile

About Sarita Sinha

Data last updated:

Sarita Sinha is a Director at Curestar Pharmaceuticals Private Limited (since 2020). The company operates in Food And Beverages. Curestar Pharmaceuticals Private Limited reported revenue of ₹26 Lakh (FY 2025).

DIN 08762878
Primary Designation Director
Industry Food And Beverages
First Appointment 15 Jun 2020
Oldest Company Age 6 yrs
Largest company Curestar Pharmaceuticals Private Limited · ₹26 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jun 20202020₹26 Lakh (FY 2025)Active

Board colleagues of Sarita Sinha

Directorship timeline

Open interactive timeline →
Curestar Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sarita Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarita Sinha

Sarita Sinha currently holds 1 directorship: Curestar Pharmaceuticals Private Limited (Director, since 15 Jun 2020, revenue ₹26 Lakh (FY 2025)).

Sarita Sinha was first appointed on 15 Jun 2020 as Director at Curestar Pharmaceuticals Private Limited.

The current boards of Sarita Sinha's companies include Amitesh Chandra (Curestar Pharmaceuticals Private Limited), Karuna Kumari (Curestar Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available